You are now leaving GSK’s website

You are now leaving a GSK Website. By clicking this link, you will be taken to a website that is not owned or controlled by GSK, and GSK is not responsible for the content provided on that site


Go back

Fluconazole 150mg


Zolanix 150mg Fluconazole is a broad spectrum systemic anti-fungal therapy for the treatment of Vulvovaginal Candidiasis and Tinea Infections such as Onychomycosis (Tinea Unguium) 1.

Learn more


What is Zolanix used for?

Zolanix is prescribed for Vulvovaginal Candidiasis and various forms of Dermatophytosis

Find out more


How effective is Zolanix?

Fluconazole provides 86% Clinical Cure Rate in Onychomycosis of the toenail with 150mg Fluconazole per week for 6 months 2

Find out more

Are you prescribing the correct dosage of fluconazole in Recurrent Vulvovaginal Candidiasis?

Find out more


  1. Zolanix BPI NCDS 04 2018.
  2. Finch JJ;Dermatologic therapy;2007;20;31-46.

Adverse Events must be reported. For products related to GSK Pakistan, please report adverse events via email at or call us at +92 (21) 111 475 725 - Ext: 7 & 8.

Full prescribing information is available on request.

GlaxoSmithKline Pakistan Limited.

35 - Dockyard Road, West Wharf, Karachi - 74000.

Zolanix is a trademark of GlaxoSmithKline group of companies.

GlaxoSmithKline Pakistan Limited is a member of GlaxoSmithKline group of companies.

© 2021 GlaxoSmithKline Pakistan Limited.